Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by HippygirL74on Sep 22, 2008 8:01pm
374 Views
Post# 15476559

Some clues

Some clues

Wayne Kay was quite tight lipped about the cardiac distributor.  He never once said, Roche, before the official announcement, but all the descriptions seemed to point to Roche.  i remember "Viewpoint" was the first to mention Roche as his choice of Cardiac distributors.   Wayne was probably dying to say "Roche" but he couldn't. 

Then at this past summer's AGM, an older gentleman asked Wayne Kay about the cash position of the company.    Wayne said that you don't have to worry about the company getting money.  He even said that maybe next year the AGM could be at RBM's new facility and that he was aware of the capital requirements.He said that he didn't want dilution and at the Roche announcement conference call, he said that the agreement was just a marketing and supply agreement not wanting to dilute and not wanting to lower transfer payments too.     He really sounded quite confident to me.  Makes me wonder what he was saying between the lines.

My guess is that he is expecting payment from 3M.  Since a sale is not recorded until the product is shipped, we have to wait for this quarterly report to see if 3M has stocked its warehouses in Australia and New Zealand and Indonesia.   3M would have to keep inventory in this area and not wait for just in time delivery from RBM as any disruption in the supply chain would be very unprofitable and expensive.  One of the worse things for 3M would be to have orders but no inventory. 

Since Avian Flu is a type of Flu A strain, these tests become very important in isolation of people at emergency wards.  i hope that Avian flu never shows its ugly head, but one has to be prepared regardless. 

imo, Wayne Kay has a pleasant surprise for us.  He just cannot say but is probably dying to say it, just like the Roche partnership. 

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse